Cart
sales@molnova.com
CP-866087
CAS No. 519052-04-1
CP-866087( —— )
Catalog No. M34558 CAS No. 519052-04-1
CP-866087 is a novel, potent and selective mu-opioid receptor antagonist for the study of female sexual dysfunction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1511 | In Stock |
|
| 25MG | 2024 | In Stock |
|
| 50MG | 2399 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCP-866087
-
NoteResearch use only, not for human use.
-
Brief DescriptionCP-866087 is a novel, potent and selective mu-opioid receptor antagonist for the study of female sexual dysfunction.
-
DescriptionCP-866087 is a novel, potent and selective mu-opioid receptor antagonist for the study of female sexual dysfunction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOpioid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number519052-04-1
-
Formula Weight376.49
-
Molecular FormulaC24H28N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C)[C@]1([C@@]2([C@]1(CN(CC3(O)CC=4C(C3)=CC=CC4)C2)[H])[H])C5=CC(C(N)=O)=CC=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
LY2444296
LY2444296 (FP3FBZ) is an orally active and selective antagonist of kappa opioid receptor(Ki = 1 nM).
-
[(pF)Phe4]Nociceptin...
Highly potent and selective nociceptin/orphanin FQ receptor (OP4) agonist peptide (pKi = 10.68; pEC50 = 9.80). Displays > 8000-fold selectivity over δ, κ, and μ opioid receptors and has relatively long lasting pronociceptive, hypotensive, negative inotropic and feeding stimulation effects in vivo.
-
Hemorphin-7
Hemorphin-7 binds to the angiotensin IV receptor, triggering multiple effects including cellular proliferation and memory enhancement. Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin. Hemorphin-7 is investigated as a potential biomarker for breast cancer.
